Paper33334019
Block-And-Lock: New Horizons for a Cure for HIV-1.
Moranguinho I and 1 other. Viruses, 2020. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. Block-And-Lock: New Horizons for a Cure for HIV-1. Papers, record 33334019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33334019
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-HIV Agents | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Antiretroviral Therapy, Highly Active | |
| CD4-Positive T-Lymphocytes | |
| Combined Modality Therapy | |
| Gene Expression Regulation, Viral | |
| Genetic Therapy | |
| Host-Pathogen Interactions | |
| Humans | |
| Proviruses | |
| Transcription, Genetic | |
| Treatment Outcome | |
| Virus Activation | |
| Virus Latency | |
| Virus Replication |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI097012 | NIAID NIH HHS | United States | R01AI097012 | PubMed and NIH | NIH RePORTER |
| R01 AI118432 | NIAID NIH HHS | United States | R01AI118432 | PubMed and NIH | NIH RePORTER |
| R33 AI116226 | NIAID NIH HHS | United States | R33AI116226 | PubMed and NIH | NIH RePORTER |
| R61 AI140439 | NIAID NIH HHS | United States | R61AI140439 | PubMed and NIH | NIH RePORTER |
References187
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29246970 | Compounds producing an effective combinatorial regimen for disruption of HIV-1 latency. | EMBO Mol Med | 2018 | https://conductscience.org/library/papers/29246970 | PubMed |
| 2 | 17449137 | RNAi therapeutics: principles, prospects and challenges. | Adv Drug Deliv Rev | 2007 | https://conductscience.org/library/papers/17449137 | PubMed |
| 3 | 23760244 | High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects. | J Virol | 2013 | https://conductscience.org/library/papers/23760244 | PubMed |
| 4 | 24658076 | New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. | Nat Med | 2014 | https://conductscience.org/library/papers/24658076 | PubMed |
| 5 | 2323336 | Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency. | EMBO J | 1990 | https://conductscience.org/library/papers/2323336 | PubMed |
| 6 | 21602280 | Impaired infectivity of ritonavir-resistant HIV is rescued by heat shock protein 90AB1. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21602280 | PubMed |
| 7 | 26169416 | Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26169416 | PubMed |
| 8 | 11940654 | Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. | Mol Cell Biol | 2002 | https://conductscience.org/library/papers/11940654 | PubMed |
| 9 | 15687388 | HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. | Nucleic Acids Res | 2005 | https://conductscience.org/library/papers/15687388 | PubMed |
| 10 | 15194784 | Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance. | J Virol | 2004 | https://conductscience.org/library/papers/15194784 | PubMed |
| 11 | 26526767 | Progress Toward HIV Eradication: Case Reports, Current Efforts, and the Challenges Associated with Cure. | Annu Rev Med | 2016 | https://conductscience.org/library/papers/26526767 | PubMed |
| 12 | 12087358 | Modulation of HIV-1 replication by RNA interference. | Nature | 2002 | https://conductscience.org/library/papers/12087358 | PubMed |
| 13 | 23300932 | Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice. | PLoS One | 2012 | https://conductscience.org/library/papers/23300932 | PubMed |
| 14 | 25587657 | Understanding HIV latency: the road to an HIV cure. | Annu Rev Med | 2015 | https://conductscience.org/library/papers/25587657 | PubMed |
| 15 | 16712471 | Inhibitors of HIV-1 Tat-mediated transactivation. | Curr Med Chem | 2006 | https://conductscience.org/library/papers/16712471 | PubMed |
| 16 | 17323593 | A review of levosimendan in the treatment of heart failure. | Vasc Health Risk Manag | 2006 | https://conductscience.org/library/papers/17323593 | PubMed |
| 17 | 16109377 | Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. | Mol Cell | 2005 | https://conductscience.org/library/papers/16109377 | PubMed |
| 18 | 25415421 | How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs? | Curr Opin HIV AIDS | 2015 | https://conductscience.org/library/papers/25415421 | PubMed |
| 19 | 12421368 | Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. | J Neurochem | 2002 | https://conductscience.org/library/papers/12421368 | PubMed |
| 20 | 27681137 | Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells. | J Virol | 2016 | https://conductscience.org/library/papers/27681137 | PubMed |
Cited by67
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42927123 | "Locking" CDK9 inhibition by activating integrator function in HIV transcription. | iScience | 2026 | https://conductscience.org/library/papers/42927123 | PubMed |
| 42824836 | Epigenetic regulation of HIV-1 transcription: insights into latency mechanisms and therapeutic strategies. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42824836 | PubMed |
| 42583667 | Underrepresentation of Africa in HIV cure research: A systematic review of the literature from 2010 to 2022. | Clin Epidemiol Glob Health | 2026 | https://conductscience.org/library/papers/42583667 | PubMed |
| 42545089 | Sorafenib enforces HIV-1 latency by selectively inhibiting PKC-driven STAT1/3 serine 727 phosphorylation. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42545089 | PubMed |
| 42515093 | Hiding in Plain Sight: HIV-1 Membraneless Organelles as Nuclear Hubs-Host Hijacking, Replication, Immune Evasion, and Drug-Access Implications. | Pathogens | 2026 | https://conductscience.org/library/papers/42515093 | PubMed |
| 42074139 | Block-and-Lock Approaches for HIV Cure: Mechanistic Insights, Challenges, and Emerging Role of CPSF6. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074139 | PubMed |
| 41993256 | Levosimendan inhibits HIV-1 infection in myeloid cells in the RIOK1-dependent manner. | bioRxiv | 2026 | https://conductscience.org/library/papers/41993256 | PubMed |
| 41628279 | Mechanistic insights and in vivo HIV suppression by the BRD4-targeting small molecule ZL0580. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/41628279 | PubMed |
| 41424846 | Searching for a HIV-1 Cure. | Theranostics | 2026 | https://conductscience.org/library/papers/41424846 | PubMed |
| 41420528 | HIV-1 establishes immediate latency in T cells expressing the viral Nef protein. | FEBS Open Bio | 2026 | https://conductscience.org/library/papers/41420528 | PubMed |
| 41373712 | Lytic or Latent Phase in Human Cytomegalovirus Infection: An Epigenetic Trigger. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373712 | PubMed |
| 41344864 | Developments in genital herpes: progress in prevention and treatment. | Curr Opin Infect Dis | 2026 | https://conductscience.org/library/papers/41344864 | PubMed |
| 40936906 | The role of Tat in HIV latency and reactivation. | Front Immunol | 2025 | https://conductscience.org/library/papers/40936906 | PubMed |
| 40849625 | Motivations, acceptability and ethical considerations for interventional HIV cure research at the end of life: perspectives from long-term survivors of HIV in the United States. | BMC Med Ethics | 2025 | https://conductscience.org/library/papers/40849625 | PubMed |
| 40726975 | Promotion of HIV clearance by sensitization of HIV reservoirs to cell death. | Front Immunol | 2025 | https://conductscience.org/library/papers/40726975 | PubMed |
| 40655347 | HIV Cure: How Far We Have Come? | Indian J Microbiol | 2025 | https://conductscience.org/library/papers/40655347 | PubMed |
| 40607797 | Genome-wide CRISPR knockout screen identifies activating transcription factor (ATF1) as an activator of HIV gene expression. | mBio | 2025 | https://conductscience.org/library/papers/40607797 | PubMed |
| 40464563 | Applications and limitations of the passenger hypothesis for HIV reservoir persistence and cure. | J Virol | 2025 | https://conductscience.org/library/papers/40464563 | PubMed |
| 40342418 | HIV-Tat upregulates the expression of senescence biomarkers in CD4+ T-cells. | Front Immunol | 2025 | https://conductscience.org/library/papers/40342418 | PubMed |
| 40335477 | BRD4 modulator ZL0580 and LEDGINs additively block and lock HIV-1 transcription. | Nat Commun | 2025 | https://conductscience.org/library/papers/40335477 | PubMed |
Genes54
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33334019
GET https://conductscience.org/api/papers/v1/33334019/references?page=2